SEC Form 4 · accession 0001053369-15-000032
ELITE PHARMACEUTICALS INC /NV/ · ELTP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Douglas Plassche
Officer — Senior VP of Operations
Period of report
Jul 23, 2013
Accepted (ET)
Jun 22, 2015 · 2:45 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001053369
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| OptionsF1 | $0.07 | Jul 23, 2013 | A | 3,000,000 | A | Jul 23, 2014 | Jul 23, 2013 | Common Stock | 3,000,000 | 3,000,000 | D |
Explanation of responses
- F11,000,000 options vested July 23, 2014, 1,000,000 options will vest July 23, 2015 and 1,000,000 options will vest July 23, 2016.